个人使用自我监测血糖市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按组件(血糖仪设备、血糖试纸、柳叶刀)和地理划分。

市场快照

personal use glucometer device market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: North America
Largest Market: North America
CAGR: 0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

  • 近年来,由于糖尿病患者意识的提高,个人使用的自我监测血糖 (SMBG) 市场有所增长。血糖仪的新技术创新及其易用性使糖尿病和糖尿病前期患者更加认真地监测和控制血糖水平。    
  • 目前,家庭用户市场占有率最高,预计还会增加。因此,在家中使用自我监测血糖仪的需求不仅在糖尿病患者中很高,而且在其他想要定期了解自己健康状况的人群中也是如此。
  • 世界上增长最快的慢性病之一是糖尿病。糖尿病是当身体的葡萄糖水平升高到超过正常水平,并且身体不能产生胰岛素时发生的疾病。血糖仪用于监测血糖水平。世界各地的 1 型糖尿病人口正在上升,同时见证了 2.13% 的复合年增长率。随着糖尿病人群的增加,自测血糖仪市场也势必会增加。
  • 其他因素,如技术创新、常规血糖监测相对于常规监测的便利性以及低血糖和高血糖糖尿病的早期检测是市场增长的主要驱动力。

报告范围

2018 年,自我监测血糖设备市场的全球家庭使用部分估计价值约为 43.993 亿美元。在预测期间(2019-2024 年),市场预计复合年增长率约为 16.4%。市场按组件(血糖仪设备、血糖试纸、柳叶刀)和地理位置进行细分。

By Usage
Personal-use Self-monitoring Blood Glucose Devices (Value and Volume, 2012 - 2024)
By Component
Glucometer Devices
Test Strips
Lancets
Geography
North America
United States (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Canada (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Rest of North America (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Europe
France (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Germany (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Italy (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Spain (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
United Kingdom (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Russia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Rest of Europe (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Latin America
Mexico (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Brazil (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Rest of Latin America (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Asia-Pacific
Japan (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
South Korea (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
China (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
By End User (Hospital and Home)
India (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
By End User (Hospital and Home)
Australia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Vietnam (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Malaysia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Indonesia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Philippines (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Thailand (Value and Volume, 2012 - 2024)
Rest of Asia-Pacific (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Middle East & Africa
Saudi Arabia (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
By End User (Hospital and Home)
Iran (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Egypt (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Oman (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
South Africa (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)
Rest of Middle & Africa (Value and Volume, 2012 - 2024)
By Device (Glucometer Device, Test Strips, Lancets)

Report scope can be customized per your requirements. Click here.

主要市场趋势

血糖试纸市场占有率最高

  • 血糖试纸在自我监测血糖(SMBG)设备的全球个人使用市场中占有最高的市场份额,达到 77%。由于血糖试纸为一次性使用,需要不断更换试纸,因此花在试纸上的费用很高。
  • 血糖仪被认为是一次性购买的。另一方面,试纸应该是一项持续的投资,因为试纸在使用后需要丢弃。因此,这对消费者造成了相当大的成本影响。  
  • 总体而言,预计全球对血糖试纸的需求在预测期内将出现显着增长。预计研究市场的增长将受到全球糖尿病患者人数增加的刺激。
  • 由于使用案例频率的差异,预计试纸细分市场的市场容量和份额的增长将好于血糖仪。虽然血糖仪的平均使用寿命在 6 个月到 3 年之间,呈现一次性成本,但在同一时间范围内,可能会相应使用多个(数千个)试纸条,从而导致经常性成本影响。
personal use glucometer device market

北美市场份额最高,复合年增长率为 21.63%

  • 北美试纸市场的市场份额最高,收入为 20 亿美元,其次是欧洲和亚太地区。
  • 仅美国就在北美血糖试纸市场占有约 80% 的份额。
  • 北美的价格政策和优惠的报销政策正在推动北美个人使用血糖仪设备市场的增长。  
personal use glucometer device market

竞争格局

  • 全球个人使用血糖仪市场高度整合,少数主要制造商在全球市场的主要区域设有业务,而其余制造商仅限于其他本地或特定区域的制造商。 
  • 自我监测血糖设备的创新正在增加并正在开发中。 
  • ColorSure® 动态范围指示器 (ColorSure® PLUS) 是对 OneTouch® 品牌的 ColorSure® 技术的扩展。ColorSure® PLUS 技术旨在帮助患者了解葡萄糖结果何时接近高点或低点。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Usage

      1. 5.1.1 Personal-use Self-monitoring Blood Glucose Devices (Value and Volume, 2012 - 2024)

    2. 5.2 By Component

      1. 5.2.1 Glucometer Devices

      2. 5.2.2 Test Strips

      3. 5.2.3 Lancets

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States (Value and Volume, 2012 - 2024)

          1. 5.3.1.1.1 By Device (Glucometer Device, Test Strips, Lancets)

        2. 5.3.1.2 Canada (Value and Volume, 2012 - 2024)

          1. 5.3.1.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.1.3 Rest of North America (Value and Volume, 2012 - 2024)

          1. 5.3.1.3.1 By Device (Glucometer Device, Test Strips, Lancets)

      2. 5.3.2 Europe

        1. 5.3.2.1 France (Value and Volume, 2012 - 2024)

          1. 5.3.2.1.1 By Device (Glucometer Device, Test Strips, Lancets)

        2. 5.3.2.2 Germany (Value and Volume, 2012 - 2024)

          1. 5.3.2.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.2.3 Italy (Value and Volume, 2012 - 2024)

          1. 5.3.2.3.1 By Device (Glucometer Device, Test Strips, Lancets)

        4. 5.3.2.4 Spain (Value and Volume, 2012 - 2024)

          1. 5.3.2.4.1 By Device (Glucometer Device, Test Strips, Lancets)

        5. 5.3.2.5 United Kingdom (Value and Volume, 2012 - 2024)

          1. 5.3.2.5.1 By Device (Glucometer Device, Test Strips, Lancets)

        6. 5.3.2.6 Russia (Value and Volume, 2012 - 2024)

          1. 5.3.2.6.1 By Device (Glucometer Device, Test Strips, Lancets)

        7. 5.3.2.7 Rest of Europe (Value and Volume, 2012 - 2024)

          1. 5.3.2.7.1 By Device (Glucometer Device, Test Strips, Lancets)

      3. 5.3.3 Latin America

        1. 5.3.3.1 Mexico (Value and Volume, 2012 - 2024)

          1. 5.3.3.1.1 By Device (Glucometer Device, Test Strips, Lancets)

        2. 5.3.3.2 Brazil (Value and Volume, 2012 - 2024)

          1. 5.3.3.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.3.3 Rest of Latin America (Value and Volume, 2012 - 2024)

          1. 5.3.3.3.1 By Device (Glucometer Device, Test Strips, Lancets)

      4. 5.3.4 Asia-Pacific

        1. 5.3.4.1 Japan (Value and Volume, 2012 - 2024)

          1. 5.3.4.1.1 By Device (Glucometer Device, Test Strips, Lancets)

        2. 5.3.4.2 South Korea (Value and Volume, 2012 - 2024)

          1. 5.3.4.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.4.3 China (Value and Volume, 2012 - 2024)

          1. 5.3.4.3.1 By Device (Glucometer Device, Test Strips, Lancets)

          2. 5.3.4.3.2 By End User (Hospital and Home)

        4. 5.3.4.4 India (Value and Volume, 2012 - 2024)

          1. 5.3.4.4.1 By Device (Glucometer Device, Test Strips, Lancets)

          2. 5.3.4.4.2 By End User (Hospital and Home)

        5. 5.3.4.5 Australia (Value and Volume, 2012 - 2024)

          1. 5.3.4.5.1 By Device (Glucometer Device, Test Strips, Lancets)

        6. 5.3.4.6 Vietnam (Value and Volume, 2012 - 2024)

          1. 5.3.4.6.1 By Device (Glucometer Device, Test Strips, Lancets)

        7. 5.3.4.7 Malaysia (Value and Volume, 2012 - 2024)

          1. 5.3.4.7.1 By Device (Glucometer Device, Test Strips, Lancets)

        8. 5.3.4.8 Indonesia (Value and Volume, 2012 - 2024)

          1. 5.3.4.8.1 By Device (Glucometer Device, Test Strips, Lancets)

        9. 5.3.4.9 Philippines (Value and Volume, 2012 - 2024)

          1. 5.3.4.9.1 By Device (Glucometer Device, Test Strips, Lancets)

        10. 5.3.4.10 Thailand (Value and Volume, 2012 - 2024)

        11. 5.3.4.11 Rest of Asia-Pacific (Value and Volume, 2012 - 2024)

          1. 5.3.4.11.1 By Device (Glucometer Device, Test Strips, Lancets)

      5. 5.3.5 Middle East & Africa

        1. 5.3.5.1 Saudi Arabia (Value and Volume, 2012 - 2024)

          1. 5.3.5.1.1 By Device (Glucometer Device, Test Strips, Lancets)

          2. 5.3.5.1.2 By End User (Hospital and Home)

        2. 5.3.5.2 Iran (Value and Volume, 2012 - 2024)

          1. 5.3.5.2.1 By Device (Glucometer Device, Test Strips, Lancets)

        3. 5.3.5.3 Egypt (Value and Volume, 2012 - 2024)

          1. 5.3.5.3.1 By Device (Glucometer Device, Test Strips, Lancets)

        4. 5.3.5.4 Oman (Value and Volume, 2012 - 2024)

          1. 5.3.5.4.1 By Device (Glucometer Device, Test Strips, Lancets)

        5. 5.3.5.5 South Africa (Value and Volume, 2012 - 2024)

          1. 5.3.5.5.1 By Device (Glucometer Device, Test Strips, Lancets)

        6. 5.3.5.6 Rest of Middle & Africa (Value and Volume, 2012 - 2024)

          1. 5.3.5.6.1 By Device (Glucometer Device, Test Strips, Lancets)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2012-2024)

    2. 6.2 Type-2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Arkray

      5. 7.1.5 Ascensia Diabetes Care

      6. 7.1.6 Agamatrix Inc.

      7. 7.1.7 Bionime Corporation

      8. 7.1.8 Acon

      9. 7.1.9 Trivida

      10. 7.1.10 Rossmax

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Personal-use Self-monitoring Blood Glucose Market market is studied from 2018 - 2026.

The Personal-use Self-monitoring Blood Glucose Market is growing at a CAGR of 0% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Roche, Abbott, Ascensia, Life scan are the major companies operating in Personal-use Self-monitoring Blood Glucose Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!